Rev. 16:2  " and there fell a noisome and grievous sore upon the men which had the mark of the beast "

Tumor studies unmentioned
The fine print on the back of the VeriChip Patient Registration Form warns customers of potential health risks, but it makes no reference to research reporting a link between embedded transponders and malignant tumors in test animals
Among risks that are mentioned: Access to the company database that stores patients' medical profiles may go down, even in emergencies. And the microchip may not work in places where there are ambient radio transmissions - such as inside ambulances or near MRI machines.

VeriChips should not be used, the registration statement warns, by children, people with blood disorders or allergies to glass, or pregnant women, among others
Those who are considering a VeriChip implant must first sign a statement, printed in capital letters, waiving any claims against the company related to the product's "merchantability and fitness
 What could happen if consumers aren't told of a product's potential risk?
http://www.starbanner.com/article/20070908/APN/709080608&template=storydetails

---

CHIPS LINKED TO CANCER
A series of veterinary and toxicology studies, dating to the mid-1990s, stated that chip implants had "induced" malignant tumors in some lab mice and rats.

"The transponders were the cause of the tumors," said Keith Johnson, a retired toxicologic pathologist, explaining in a phone interview the findings of a 1996 study he led at the Dow Chemical Co. in Midland, Mich.

Leading cancer specialists reviewed the research for The Associated Press and, while cautioning that animal test results do not necessarily apply to humans, said the findings troubled them. Some said they would not allow family members to receive implants, and all urged further research before the glass-encased transponders are widely implanted in people.

Did the agency know of the tumor findings before approving the chip implants? The FDA declined repeated AP requests to specify what studies it reviewed.

The FDA is overseen by the Department of Health and Human Services, which, at the time of VeriChip's approval, was headed by Tommy Thompson. Two weeks after the device's approval took effect on Jan. 10, 2005, Thompson left his Cabinet post, and within five months was a board member of VeriChip Corp. and Applied Digital Solutions. He was compensated in cash and stock options.

Also making no mention of the findings on animal tumors was a June report by the ethics committee of the American Medical Association, which touted the benefits of implantable RFID devices.

Had committee members reviewed the literature on cancer in chipped animals?

No, said Dr. Steven Stack, an AMA board member with knowledge of the committee's review.

Was the AMA aware of the studies?
In 1997, a study in Germany found cancers in 1 percent of 4,279 chipped mice. The tumors "are clearly due to the implanted microchips," the authors wrote
There's no way in the world, having read this information, that I would have one of those chips implanted in my skin, or in one of my family members," said Dr. Robert Benezra, head of the Cancer Biology Genetics Program at the Memorial Sloan-Kettering Cancer Center in New York.

Before microchips are implanted on a large scale in humans, he said, testing should be done on larger animals, such as dogs or monkeys. "I mean, these are bad diseases. They are life-threatening. And given the preliminary animal data, it looks to me that there's definitely cause for concern

In humans, sarcomas, which strike connective tissues, can range from the highly curable to "tumors that are incredibly aggressive and can kill people in three to six months," he said.

When the FDA approved the device, it noted some Verichip risks: The capsules could migrate around the body, making them difficult to extract; they might interfere with defibrillators, or be incompatible with MRI scans, causing burns. While also warning that the chips could cause "adverse tissue reaction," FDA made no reference to malignant growths in animal studies

http://www.journalgazette.net/apps/pbcs.dll/article?AID=/20070908/APN/709080608&template=apart

CANCER CHIP
http://blog.wired.com/sterling/2007/09/arphid-watch-ar.html